BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Brixner D, Mittal M, Rubin DT, Mease P, Liu HH, Davis M, Ganguli A, Fendrick AM. Participation in an innovative patient support program reduces prescription abandonment for adalimumab-treated patients in a commercial population. Patient Prefer Adherence 2019;13:1545-56. [PMID: 31571837 DOI: 10.2147/PPA.S215037] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Gilkey MB, Cripps LA, Przywara KM, Batista MI, Galbraith AA. Strategies commercially-insured families use to manage the cost of asthma care: A qualitative interview study. J Asthma 2022;:1-14. [PMID: 35037558 DOI: 10.1080/02770903.2022.2030749] [Reference Citation Analysis]
2 Mittal M, Yang M, Shah M, Gao W, Carley C, Sherman BW. Impact of Medication Adherence on Healthcare Resource Utilization, Work Loss, and Associated Costs in a Privately Insured Employed Population Treated With Adalimumab in the United States. J Occup Environ Med 2021;63:e724-31. [PMID: 34412091 DOI: 10.1097/JOM.0000000000002354] [Reference Citation Analysis]
3 Argenziano G, Amerio P, Aragone MG, Baggini G, Baldari M, Castelli G, Coppola S, Costanzo A, De Pasquale R, Fargnoli MC, Foti C, Giofrè C, Lembo S, Leporati C, Loconsole F, Malara G, Peris K, Richetta AG, Savoia P, Tiberio R, Travaglini M, Uzzauto MT, Bianchi L. Assessing the Beneficial Impact of a Patient Support Program in Secukinumab-Treated Patients with Psoriasis in Italy. Patient Prefer Adherence 2021;15:2551-62. [PMID: 34824526 DOI: 10.2147/PPA.S326498] [Reference Citation Analysis]